Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Castration-resistant Prostate Cancer × testosterone enanthate × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 2 Castration Resistant Metastatic Prostate Cancer 2 Castration-resistant Prostate Cancer 1 Castration-Resistant Prostate Carcinoma 1

Interventions

enzalutamide 3 Abiraterone Acetate 2 testosterone enanthate 1 pembrolizumab 1 disitamab vedotin 1 abiraterone 1 Radium-223 1 Prednisone 1 Ketoconazole 1 Hydrocortisone 1 Flutamide 1 Calcitriol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03522064 2025-05-15

HiTeCH

St Vincent's Hospital, Sydney

Phase 2 Recruiting

Castration-resistant Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡